Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet Hardy

Showing results (31-40 of 96) with videos related to

Pageof 10
Sort By:
BMJ Supportive & Palliative Care|September 25, 2023
Drug dependence epidemiology in palliative care medicinal cannabis trialsChee Yen Lee, Phillip Good, Georgie Huggett, et al.
Journal of Clinical Pharmacology|September 19, 2015
Exposure to Fentanyl After Transdermal Patch Administration for Cancer Pain ManagementSudeep R Bista, Alison Haywood, Janet Hardy, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 15, 2015
Interventional options for the management of refractory cancer pain--what is the evidence?Petra Vayne-Bossert, Banafsheh Afsharimani, Phillip Good, et al.
BMJ Supportive & Palliative Care|January 20, 2022
Oral water-soluble contrast for malignant bowel obstruction: open label pilot studyWan Fadzrul Izuan Bin Wan Bahrum, Janet Hardy, Karyn Foster, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 1, 2013
Should the dosage of controlled-release oxycodone in advanced cancer be modified on the basis of patient characteristics?Bruce Charles, Janet Hardy, Helen Anderson, et al.
BMJ Supportive & Palliative Care|June 4, 2024
Psychological distress and physical symptoms in advanced cancer: cross-sectional studyBridget Podbury, Taylan Gurgenci, Georgie Huggett, et al.
BMJ Supportive & Palliative Care|February 2, 2024
Cannabidiol oil or placebo in advanced cancer-disease progression and survival: a secondary analysisCian O'Leary, Ristan Greer, Georgie Huggett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 21, 2022
Phase IIb Randomized, Placebo-Controlled, Dose-Escalating, Double-Blind Study of Cannabidiol Oil for the Relief of Symptoms in Advanced Cancer (MedCan1-CBD)Janet Hardy, Ristan Greer, Georgie Huggett, et al.
BMJ Supportive & Palliative Care|November 15, 2022
Medicinal cannabis in palliative medicine: lessons learnt from randomised controlled trialsTaylan Gurgenci, Janet Hardy, Rebecca Olson, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 19, 2016
A randomised, double-blind controlled trial of intranasal midazolam for the palliation of dyspnoea in patients with life-limiting diseaseJanet Hardy, Clare Randall, Eve Pinkerton, et al.
Pageof 10

Showing results (31-40 of 96) with videos related to

Sort By:
Pageof 10
BMJ Supportive & Palliative Care|September 25, 2023
Drug dependence epidemiology in palliative care medicinal cannabis trialsChee Yen Lee, Phillip Good, Georgie Huggett, et al.
Journal of Clinical Pharmacology|September 19, 2015
Exposure to Fentanyl After Transdermal Patch Administration for Cancer Pain ManagementSudeep R Bista, Alison Haywood, Janet Hardy, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 15, 2015
Interventional options for the management of refractory cancer pain--what is the evidence?Petra Vayne-Bossert, Banafsheh Afsharimani, Phillip Good, et al.
BMJ Supportive & Palliative Care|January 20, 2022
Oral water-soluble contrast for malignant bowel obstruction: open label pilot studyWan Fadzrul Izuan Bin Wan Bahrum, Janet Hardy, Karyn Foster, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 1, 2013
Should the dosage of controlled-release oxycodone in advanced cancer be modified on the basis of patient characteristics?Bruce Charles, Janet Hardy, Helen Anderson, et al.
BMJ Supportive & Palliative Care|June 4, 2024
Psychological distress and physical symptoms in advanced cancer: cross-sectional studyBridget Podbury, Taylan Gurgenci, Georgie Huggett, et al.
BMJ Supportive & Palliative Care|February 2, 2024
Cannabidiol oil or placebo in advanced cancer-disease progression and survival: a secondary analysisCian O'Leary, Ristan Greer, Georgie Huggett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 21, 2022
Phase IIb Randomized, Placebo-Controlled, Dose-Escalating, Double-Blind Study of Cannabidiol Oil for the Relief of Symptoms in Advanced Cancer (MedCan1-CBD)Janet Hardy, Ristan Greer, Georgie Huggett, et al.
BMJ Supportive & Palliative Care|November 15, 2022
Medicinal cannabis in palliative medicine: lessons learnt from randomised controlled trialsTaylan Gurgenci, Janet Hardy, Rebecca Olson, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 19, 2016
A randomised, double-blind controlled trial of intranasal midazolam for the palliation of dyspnoea in patients with life-limiting diseaseJanet Hardy, Clare Randall, Eve Pinkerton, et al.
Pageof 10